Updated Jul 16, 2026
MCGRATH DENNIS M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Dennis M. McGrath is a corporate executive known for his roles as President and CFO at Citius Oncology Inc. and as a director at several other companies, including PAVmed Inc. and DarioHealth Corp. He has been involved in the biopharmaceutical sector, focusing on oncology therapies.
| Role | President and CFO |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-03 | PAVM | PAVmed Inc. | A — Grant or award | 180.0K | $0.00 | |
| 2026-02-24 | LUCD | Lucid Diagnostics Inc. | A — Grant or award | 470.0K | $0.00 | |
| 2025-12-22 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 | |
| 2025-12-01 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 | |
| 2025-09-30 | PAVM | PAVmed Inc. | A — Grant or award | 150.0K | $0.00 | |
| 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | A — Grant or award | 300.0K | $0.00 | |
| 2025-09-11 | DRIO | DarioHealth Corp. | A — Grant or award | 20.0K | $0.00 |
Dennis M. McGrath is a corporate executive known for his roles as President and CFO at Citius Oncology Inc. and as a director at several other companies, including PAVmed Inc. and DarioHealth Corp. He has been involved in the biopharmaceutical sector, focusing on oncology therapies.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MCGRATH DENNIS M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.